Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling

por Hobbs, R, Fu, D, Pomper, M, Ambinder, R, Sgouros, G
Publicado 2009

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

por Ratner, L, Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, S K, Parekh, S, Ramos, J C, Ambinder, R, Phillips, A, Harding, J, Baydoun, H H, Cheng, X, Jacobson, S
Publicado 2016